InvestorsHub Logo
Followers 45
Posts 5134
Boards Moderated 0
Alias Born 01/27/2012

Re: XenaLives post# 220996

Tuesday, 11/26/2019 12:02:00 PM

Tuesday, November 26, 2019 12:02:00 PM

Post# of 458966
Could be! The clock started for me when, in 2014 I believe, the FDA announced a new adaptive open label trial design and Anavex step right up and said “yup, this is our plan!”. Now your thought is that Dr. M already had plans of AU in the works with the starting gun or after a year of FDAHUTA (head up their a-s)? Either say this company is heavily armoured with current running trials, and thats only what we know about. I still remember the “backlog” in the FDA over ODD awards that they were regearing to process faster.

Picking up steam on a unstoppable cellular homeostasis train!

Tred
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News